A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-16 ◽

2014 ◽

Vol 2 (1) ◽

Author(s):

Paul LR Mitchell ◽

Michael A Quinn ◽

Peter T Grant ◽

David G Allen ◽

Thomas W Jobling ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Epithelial Ovarian Cancer ◽

Phase 2 ◽

Autologous Dendritic Cell ◽

Mucin 1 ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-s3-p72 ◽

2014 ◽

Vol 2 (S3) ◽

Author(s):

Sharron Gargosky ◽

Canvas Clinical Team

Keyword(s):

Ovarian Cancer ◽

Overall Survival ◽

Dendritic Cell ◽

Cell Therapy ◽

Epithelial Ovarian Cancer ◽

Autologous Dendritic Cell ◽

Mucin 1 ◽

Dendritic Cell Therapy

Download Full-text

519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)72453-4 ◽

2008 ◽

Vol 6 (12) ◽

pp. 164-165 ◽

Author(s):

C.M. Matthews ◽

S.N. Ho ◽

M. Barve ◽

K.M. Bell-McGuinn ◽

L. Gilbert ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase 2 ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Resistant ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Progression-free survival in ovarian cancer patients in second remission with mucin-1 autologous dendritic cell therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5504 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5504-5504 ◽

Author(s):

Heidi J. Gray ◽

Sharron Erna Gargosky ◽

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Cell Therapy ◽

Cancer Patients ◽

Progression Free Survival ◽

Autologous Dendritic Cell ◽

Mucin 1 ◽

Free Survival ◽

Dendritic Cell Therapy

Download Full-text

Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps3134 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS3134-TPS3134

Author(s):

Lukas Rob ◽

Jirina Bartunkova ◽

David Cibula ◽

Pawel Knapp ◽

Zuzana Namestkova ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Standard Of Care ◽

Dendritic Cell Vaccination ◽

Advanced Stage ◽

Phase 2 ◽

Autologous Dendritic Cell ◽

Randomized Phase 2

Download Full-text

Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/0090-8258(92)90139-a ◽

1992 ◽

Vol 47 (3) ◽

pp. 353-357 ◽

Author(s):

Maurie Markman ◽

Bonnie Reichman ◽

Thomas Hakes ◽

Stephen Rubin ◽

Walter Jones ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Salvage Treatment ◽

Phase 2 ◽

Phase 2 Trial ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Phase 2 Study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80749-3 ◽

2002 ◽

Vol 38 ◽

pp. S34-S35

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase 2 ◽

Phase 2 Study ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

Gynecologic Oncology ◽

10.1006/gyno.1996.0308 ◽

1996 ◽

Vol 63 (2) ◽

pp. 210-215 ◽

Author(s):

Hanne Havsteen ◽

Kamma Bertelsen ◽

Carl C. Gadeberg ◽

Anders Jacobsen ◽

Claus Kamby ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Line Treatment ◽

Second Line ◽

Phase 2 ◽

Phase 2 Study ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-1-s1-p213 ◽

2013 ◽

Vol 1 (S1) ◽

Author(s):

J Goh ◽

J Mason ◽

J Chan ◽

M Moradi ◽

J Berek ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Cell Therapy ◽

Cancer Patients ◽

Autologous Dendritic Cell ◽

Mucin 1 ◽

Dendritic Cell Therapy

Download Full-text

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

Journal for ImmunoTherapy of Cancer ◽

10.1186/s40425-016-0137-x ◽

2016 ◽

Vol 4 (1) ◽

Author(s):

H. J. Gray ◽

B. Benigno ◽

J. Berek ◽

J. Chang ◽

J. Mason ◽

...

Keyword(s):

Ovarian Cancer ◽

Overall Survival ◽

Dendritic Cell ◽

Cell Therapy ◽

Cancer Patients ◽

Phase 2 ◽

Mucin 1 ◽

Phase 2 Trial ◽

Dendritic Cell Therapy ◽

Randomized Phase 2

Download Full-text

3 - Impact of introducing extensive surgical procedures to Cytoreductive Surgery (CRS) in advanced Epithelial Ovarian Cancer (EOC) on rate of complete debulking (CD) and survival

10.26226/morressier.5d2ee8e71e09a6f49485a8f0 ◽

2019 ◽

Author(s):

Seoud Muhieddine

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Surgical Procedures ◽

Cytoreductive Surgery ◽

Advanced Epithelial Ovarian Cancer

Download Full-text